Author
Listed:
- Kamaleldin B. Said
(Department of Pathology, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia
Genomics, Bioinformatics and Systems Biology, Carleton University, 1125 Colonel-By Dr, Ottawa, ON K1S 5B6, Canada
ASC, McGill University, 21111 Lakeshore Rd, Montreal, QC H9X 3L9, Canada)
- Ahmed Alsolami
(Department of Internal Medicine, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Safia Moussa
(Department of Microbiology, King Salman Specialist Hospital, Ha’il 55476, Saudi Arabia)
- Fayez Alfouzan
(Department of Microbiology, King Salman Specialist Hospital, Ha’il 55476, Saudi Arabia)
- Abdelhafiz I. Bashir
(Department of Physiology, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Musleh Rashidi
(Ministry of Health, Hail Region, Ha’il 55476, Saudi Arabia)
- Rana Aborans
(Department of Community Medicine, Faculty of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Taha E. Taha
(Department of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA)
- Husam Almansour
(Health Management Department, College of Public Health and Health Informatics, University of Ha’il, Ha’il 81481, Saudi Arabia)
- Mashari Alazmi
(College of Computer Science and Engineering, University of Ha’il, Ha’il 81481, Saudi Arabia)
- Amal Al-Otaibi
(Department of Pathology, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Luluh Aljaloud
(Department of Pathology, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Basmah Al-Anazi
(Department of Pathology, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Ahmed Mohialdin
(Department of Surgery, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
- Ahmed Aljadani
(Department of Internal Medicine, College of Medicine, University of Ha’il, Ha’il 55476, Saudi Arabia)
Abstract
Bacterial co-infections may aggravate COVID-19 disease, and therefore being cognizant of other pathogens is imperative. We studied the types, frequency, antibiogram, case fatality rates (CFR), and clinical profiles of co-infecting-pathogens in 301 COVID-19 patients. Co-infection was 36% ( n = 109), while CFR was 31.2% compared to 9.9% in non-co-infected patients (z-value = 3.1). Four bacterial species dominated, namely, multidrug-resistant Klebsiella pneumoniae (37%, n = 48), extremely drug-resistant Acinetobacter baumannii (26%, n = 34) , multidrug-resistant Eschericia. coli (18.6%, n = 24), and extremely drug-resistant Pseudomonas aeruginosa (8.5%, n = 11), in addition to other bacterial species (9.3%, n = 12). Increased co-infection of K. pneumoniae and A. baumannii was associated with increased death rates of 29% ( n = 14) and 32% ( n = 11), respectively. Klebsiella pneumoniae was equally frequent in respiratory and urinary tract infections (UTI), while E. coli mostly caused UTI (67%), and A. baumannii and P. aeruginosa dominated respiratory infections (38% and 45%, respectively). Co-infections correlated with advance in age: seniors ≥ 50 years (71%), young adults 21–49 years (25.6%), and children 0–20 years (3%). These findings have significant clinical implications in the successful COVID-19 therapies, particularly in geriatric management. Future studies would reveal insights into the potential selective mechanism(s) of Gram-negative bacterial co-infection in COVID-19 patients.
Suggested Citation
Kamaleldin B. Said & Ahmed Alsolami & Safia Moussa & Fayez Alfouzan & Abdelhafiz I. Bashir & Musleh Rashidi & Rana Aborans & Taha E. Taha & Husam Almansour & Mashari Alazmi & Amal Al-Otaibi & Luluh Al, 2022.
"COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria,"
IJERPH, MDPI, vol. 19(9), pages 1-16, April.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:9:p:5270-:d:802584
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:9:p:5270-:d:802584. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.